We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+27.04%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$329B
AUM Growth
+$45.5B
Cap. Flow
-$19.5B
Cap. Flow %
-5.91%
Top 10 Hldgs %
19.09%
Holding
5,697
New
507
Increased
1,879
Reduced
2,401
Closed
535

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.38B
2
AGN
Allergan plc
AGN
+$1.33B
3
MSFT icon
Microsoft
MSFT
+$961M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$803M
5
AMZN icon
Amazon
AMZN
+$740M

Sector Composition

Rank Sector Weight
1 Technology 14.8%
2 Healthcare 9.1%
3 Financials 9.05%
4 Consumer Discretionary 8.76%
5 Communication Services 6.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBIO icon
4801
iBio
IBIO
$72.5M
$156K ﹤0.01%
140
-54
-28% -$35.3K
LHC.WS
4802
DELISTED
Leo Holdings Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exe
LHC.WS
$156K ﹤0.01%
125,000
ALDX icon
4803
Aldeyra Therapeutics
ALDX
$93.5M
$155K ﹤0.01%
37,073
+9,124
+33% +$33.3K
MNOV icon
4804
MediciNova
MNOV
$64M
$155K ﹤0.01%
28,566
-1,915
-6% -$10.2K
OGI
4805
Organigram Holdings
OGI
$140M
$155K ﹤0.01%
24,823
+8,435
+51% +$56.8K
KBLMW
4806
DELISTED
KBL Merger Corp. IV Warrant
KBLMW
$154K ﹤0.01%
500,000
WRAP icon
4807
Wrap Technologies
WRAP
$110M
$153K ﹤0.01%
+14,606
New +$87.5K
ELVT
4808
DELISTED
Elevate Credit, Inc.
ELVT
$153K ﹤0.01%
103,436
+26,448
+34% +$46.2K
MYJ
4809
DELISTED
Blackrock Muni Yield New Jersey Fund, Inc.
MYJ
$153K ﹤0.01%
11,249
-6,986
-38% -$92.9K
STEX
4810
Streamex Corp
STEX
$81.2M
$151K ﹤0.01%
2,100
+940
+81% +$81.8K
LJPC
4811
DELISTED
La Jolla Pharmaceutical Company
LJPC
$151K ﹤0.01%
35,553
+14,358
+68% +$87.4K
OMP
4812
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
$148K ﹤0.01%
16,944
SAMG icon
4813
Silvercrest Asset Management
SAMG
$79.9M
$147K ﹤0.01%
11,558
-3,998
-26% -$42.4K
TELL
4814
DELISTED
Tellurian Inc.
TELL
$147K ﹤0.01%
127,858
+11,970
+10% +$15.1K
TRVN
4815
DELISTED
Trevena, Inc.
TRVN
$146K ﹤0.01%
+156
New +$104K
PKBK icon
4816
Parke Bancorp
PKBK
$401M
$145K ﹤0.01%
+10,681
New +$137K
TPST icon
4817
Tempest Therapeutics
TPST
$14.2M
$145K ﹤0.01%
423
+329
+350% +$131K
SLCT
4818
DELISTED
Select Bancorp, Inc.
SLCT
$145K ﹤0.01%
+17,817
New +$134K
GDYNW
4819
DELISTED
Grid Dynamics Holdings, Inc. Warrant
GDYNW
$144K ﹤0.01%
90,000
FCEL icon
4820
FuelCell Energy
FCEL
$1.8B
$143K ﹤0.01%
+2,106
New +$130K
KOPN icon
4821
Kopin
KOPN
$769M
$143K ﹤0.01%
107,179
-146
-0.1% -$122
EOLS icon
4822
Evolus
EOLS
$403M
$141K ﹤0.01%
26,585
-23,061
-46% -$106K
SCPH
4823
DELISTED
scPharmaceuticals
SCPH
$140K ﹤0.01%
19,012
+1,864
+11% +$16.4K
VCV icon
4824
Invesco California Value Municipal Income Trust
VCV
$518M
$140K ﹤0.01%
11,993
-20,021
-63% -$228K
VPV icon
4825
Invesco Pennsylvania Value Municipal Income Trust
VPV
$195M
$138K ﹤0.01%
11,599
-1
-0% -$12

Similar funds

Goldman Sachs's Q2 2020 Portfolio in Review

As of Q2 2020, Goldman Sachs held 5,697 positions worth $329B, up 16% from $284B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Goldman Sachs withdrew a net $19.5B in Q2 2020, closing 535 positions and reducing 2,401 holdings. Its most notable exit was Allergan plc, an estimated $1.33B position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Goldman Sachs opened a new position in Goldman Sachs MarketBeta US Equity ETF worth $209M.

  • Goldman Sachs's largest Q2 2020 buy was Goldman Sachs MarketBeta US Equity ETF: 4,910,076 shares worth $209M.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $2.58B increase.
  • Goldman Sachs's biggest Q2 2020 reduction was Apple, cutting an estimated $1.38B.
  • Goldman Sachs fully exited Allergan plc in Q2 2020, selling an estimated $1.33B.
  • Goldman Sachs's ten largest holdings make up 19% of its $329B portfolio in Q2 2020.
  • Goldman Sachs opened 507 new positions and closed 535 in Q2 2020.
  • Goldman Sachs's portfolio value rose 16% quarter-over-quarter to $329B.

Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.